100 related articles for article (PubMed ID: 1492229)
21. A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Wallerstein R; Spitzer G; Dunphy F; Huan S; Hortobagyi G; Yau J; Buzdar A; Holmes F; Theriault R; Ewer M
J Clin Oncol; 1990 Nov; 8(11):1782-8. PubMed ID: 2121909
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
Slevin ML; Clark PI; Joel SP; Malik S; Osborne RJ; Gregory WM; Lowe DG; Reznek RH; Wrigley PF
J Clin Oncol; 1989 Sep; 7(9):1333-40. PubMed ID: 2549204
[TBL] [Abstract][Full Text] [Related]
23. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
[TBL] [Abstract][Full Text] [Related]
24. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
25. Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer.
Fields KK; Elfenbein GJ; Perkins JB; Ballester OF; Goldstein SC; Heimenz JW; Saez RA; Sullivan DM; Partyka JS; Kronish LA
Semin Oncol; 1998 Apr; 25(2 Suppl 4):1-6; discussion 45-8. PubMed ID: 9578055
[TBL] [Abstract][Full Text] [Related]
26. Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association.
Thomas GW; Muss HB; Jackson DV; McCulloch J; Ramseur W; McFarland J; Hoen H; Pavy M; Heath R
Cancer Chemother Pharmacol; 1994; 35(2):165-8. PubMed ID: 7987995
[TBL] [Abstract][Full Text] [Related]
27. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
Bonomi P; Kim K; Fairclough D; Cella D; Kugler J; Rowinsky E; Jiroutek M; Johnson D
J Clin Oncol; 2000 Feb; 18(3):623-31. PubMed ID: 10653877
[TBL] [Abstract][Full Text] [Related]
28. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
29. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.
Pujol JL; Carestia L; Daurès JP
Br J Cancer; 2000 Jul; 83(1):8-15. PubMed ID: 10883661
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide in advanced/disseminated breast cancer.
Sorio R; Lombardi D; Spazzapan S; La Mura N; Tabaro G; Veronesi A
Oncology; 2003; 65 Suppl 2():55-8. PubMed ID: 14586149
[TBL] [Abstract][Full Text] [Related]
31. High-dose etoposide (VP-16) in small-cell lung cancer.
Greco FA; Johnson DH; Hande KR; Porter LL; Hainsworth JD; Wolff SN
Semin Oncol; 1985 Mar; 12(1 Suppl 2):42-4. PubMed ID: 2983434
[TBL] [Abstract][Full Text] [Related]
32. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
33. Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines.
Kalemkerian GP; Ou X
Cancer Chemother Pharmacol; 1999; 43(2):145-50. PubMed ID: 9923820
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer.
Tolcher AW
Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035
[TBL] [Abstract][Full Text] [Related]
35. Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
Feliu J; González Barón M; Zamora P; Garcia Alfonso P; Garcia Girón C; Blanco E; Belón J; Garrido P; Jara C; Ruiz A; Vincent JM; Espinosa E
Oncology; 1997; 54 Suppl 1():30-7. PubMed ID: 8978582
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for breast cancer brain metastases.
Fenner MH; Possinger K
Onkologie; 2002 Oct; 25(5):474-9. PubMed ID: 12415203
[TBL] [Abstract][Full Text] [Related]
37. A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
Hammond LA; Eckardt JR; Ganapathi R; Burris HA; Rodriguez GA; Eckhardt SG; Rothenberg ML; Weiss GR; Kuhn JG; Hodges S; Von Hoff DD; Rowinsky EK
Clin Cancer Res; 1998 Jun; 4(6):1459-67. PubMed ID: 9626463
[TBL] [Abstract][Full Text] [Related]
38. Oral etoposide in small cell lung cancer.
Carney DN; Keane M; Grogan L
Semin Oncol; 1992 Dec; 19(6 Suppl 14):40-4. PubMed ID: 1336899
[TBL] [Abstract][Full Text] [Related]
39. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
Athanassiades P; Bacoyiannes H; Kontoyiannes D
Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
[TBL] [Abstract][Full Text] [Related]
40. Etoposide. Current and future status.
Aisner J; Lee EJ
Cancer; 1991 Jan; 67(1 Suppl):215-9. PubMed ID: 1984822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
